Leading Manufacturer & Exporter of Hydralazine Hydrochloride Injection 20mg/ml (Hydrataj)

Taj Pharmaceuticals Ltd, headquartered in Mumbai with world-class manufacturing facilities in Vapi, Gujarat, stands as one of the most trusted and reputed manufacturers, exporters, and suppliers of Hydralazine Hydrochloride Injection 20mg/ml (Hydrataj) in India and across global markets. With an unwavering commitment to quality, purity, and compliance with international standards, Taj Pharma has earned a strong presence in Africa, the Middle East, LATAM, and other emerging markets.

About Hydralazine Hydrochloride Injection (Hydrataj)

Hydralazine Hydrochloride Injection belongs to the class of vasodilators, specifically designed to treat severe or life-threatening hypertension when oral administration is not possible or when there is an urgent need for rapid blood pressure reduction in hospitalized patients.

This injection works by relaxing and enlarging small blood vessels, enabling smoother blood flow, reducing vascular resistance, and lowering blood pressure. The onset of action can be seen within minutes, with maximum blood pressure reduction typically occurring between 10–80 minutes after administration.

Why Choose Taj Pharma for Hydralazine Hydrochloride Injection?

1. WHO-GMP & ISO Certified Facilities

Taj Pharma manufactures Hydralazine Hydrochloride Injection in state-of-the-art, WHO-GMP compliant plants with ISO certification. Each batch is tested rigorously to meet pharmacopoeial standards such as IP, BP, and USP.

2. Global Export Reach

As a pioneer exporter in the pharmaceutical sector, Taj Pharma supplies Hydralazine Hydrochloride Injection to hospitals, government health programs, and private healthcare providers in Africa, the Middle East, LATAM, CIS countries, and Asia.

3. Compliance & Documentation

All exports are accompanied by complete regulatory dossiers including COA (Certificate of Analysis), MSDS (Material Safety Data Sheet), COPP (Certificate of Pharmaceutical Product), and stability data as per ICH guidelines.

Therapeutic Indications

Hydralazine Hydrochloride Injection is indicated for:

• Severe hypertension requiring immediate intervention.
• Hypertensive crisis in emergency settings.
• Pregnancy-induced hypertension (PIH) when other options are unsuitable.
• Acute heart failure (adjunct therapy).

Dosage & Administration

• Strength: 20mg/ml.
• Route of Administration: Intravenous (IV) or Intramuscular (IM) under the supervision of a healthcare professional.
• Dosage: Adjusted according to patient’s blood pressure and response. In patients with renal impairment, a lower dose may be required.
• Onset of Action: 5–20 minutes (IV), 20–30 minutes (IM).
• Duration: 2–6 hours.

Important: This medicine must be administered only by trained medical professionals in a hospital or clinical setting.

Safety & Precautions

• Pregnancy: May be unsafe; should be prescribed only if benefits outweigh risks.
• Breastfeeding: Generally considered safe; minimal transfer into breast milk.
• Alcohol: Strictly avoid alcohol during treatment as it can enhance hypotensive effects.
• Driving/Operating Machinery: Patients should avoid driving if they experience dizziness, headaches, or concentration difficulties.

Possible Side Effects

Some patients may experience:

• Headache
• Loss of appetite
• Nausea or vomiting
• Diarrhea
• Increased heart rate (tachycardia)
• Flushing
• Dizziness

Persistent or severe side effects should be reported to a healthcare provider immediately.

Storage Instructions

• Store below 25°C in a dry place away from direct sunlight.
• Protect from freezing.
• Use immediately after opening the ampoule.
• Do not mix with other solutions.
• Discard any discolored or contaminated solutions.

Technical Specifications – Hydralazine Hydrochloride Injection (Hydrataj)

Hydralazine Hydrochloride Injection for PCD Pharma Franchise & Third-Party Manufacturing

Taj Pharma offers third-party manufacturing and PCD pharma franchise opportunities for Hydralazine Hydrochloride Injection at competitive prices. With a robust supply chain, flexible MOQs, and attractive marketing support, Taj Pharma is a trusted partner for businesses looking to expand their pharmaceutical portfolio.

Global Export Expertise

Taj Pharmaceuticals has established strong partnerships with government tenders, NGOs, and institutional buyers worldwide. With years of export experience, Taj Pharma ensures timely delivery, regulatory compliance, and consistent product quality.

Export regions include:

• Africa: Nigeria, Kenya, Ghana, Uganda, South Africa
• Middle East: UAE, Saudi Arabia, Oman, Yemen
• LATAM: Brazil, Peru, Mexico, Colombia
• Asia: Vietnam, Philippines, Bangladesh

Why Hydralazine Hydrochloride Injection is Crucial in Modern Healthcare

Hypertension remains a leading cause of stroke, heart attack, kidney damage, and cardiovascular death worldwide. In emergencies where immediate blood pressure control is critical, Hydralazine Hydrochloride Injection serves as a lifesaving intervention. Its rapid vasodilatory action helps stabilize patients and prevents severe complications.

Ordering & Enquiries

If you are a pharma distributor, hospital buyer, or government procurement agency, Taj Pharma offers the best deals on bulk and institutional purchases of Hydralazine Hydrochloride Injection.

📧 Email: info@tajpharma.com
🌍 Website: www.tajpharma.com
📞 Call/WhatsApp: +91 84484 44095
📠 Fax: +91 – 22 – 2634 1274

Hydralazine Hydrochloride Injection (Hydrataj) from Taj Pharma is backed by years of research, compliance, and manufacturing excellence. Whether for domestic use or international supply, Taj Pharma ensures each ampoule meets the highest standards of safety, efficacy, and purity.